Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
PHASE2CompletedINTERVENTIONAL
Enrollment
170
Participants
Timeline
Start Date
July 31, 1995
Conditions
Cystic FibrosisBacterial Infections
Interventions
DRUG
mucoid exopolysaccharide P. aeruginosa immune globulin IV
All Listed Sponsors
collaborator
Vanderbilt University Medical Center
OTHER
lead
National Center for Research Resources (NCRR)
NIH
NCT00004747 - Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis | Biotech Hunter | Biotech Hunter